8-chloro-2-[6-(trideuteriomethoxy)-3-pyridyl]-5H-pyrazolo[4,3-c]quinolin-3-one

ID: ALA4064653

Chembl Id: CHEMBL4064653

PubChem CID: 124111405

Max Phase: Preclinical

Molecular Formula: C16H11ClN4O2

Molecular Weight: 326.74

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  [2H]C([2H])([2H])Oc1ccc(-n2nc3c4cc(Cl)ccc4[nH]cc-3c2=O)cn1

Standard InChI:  InChI=1S/C16H11ClN4O2/c1-23-14-5-3-10(7-19-14)21-16(22)12-8-18-13-4-2-9(17)6-11(13)15(12)20-21/h2-8,18H,1H3/i1D3

Standard InChI Key:  UUYVENWWOUEDPQ-FIBGUPNXSA-N

Associated Targets(Human)

Liver (3974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRG2 Tclin GABA-A receptor; alpha-6/beta-3/gamma-2 (367 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Liver (8163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 326.74Molecular Weight (Monoisotopic): 326.0571AlogP: 2.88#Rotatable Bonds: 2
Polar Surface Area: 72.80Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.47CX Basic pKa: 2.32CX LogP: 2.24CX LogD: 2.24
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.61Np Likeness Score: -1.66

References

1. Knutson DE, Kodali R, Divović B, Treven M, Stephen MR, Zahn NM, Dobričić V, Huber AT, Meirelles MA, Verma RS, Wimmer L, Witzigmann C, Arnold LA, Chiou LC, Ernst M, Mihovilovic MD, Savić MM, Sieghart W, Cook JM..  (2018)  Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABAAR) α6 Subtype with Improved Metabolic Stability and Enhanced Bioavailability.,  61  (6): [PMID:29481759] [10.1021/acs.jmedchem.7b01664]

Source